logo
Revolut profit more than doubles to €922m as it eyes mortgages launch

Revolut profit more than doubles to €922m as it eyes mortgages launch

Irish Times24-04-2025
Revolut's net profit more than doubled last year to £790 million (€922 million), driven by card fees and interest earned on surplus deposits placed with central banks, as the London-based fintech prepares to boost its lending by launching mortgages this year.
Profit for the year rose by 129 per cent, according to Revolut's latest annual report, published on Thursday.
Group revenues rose by 72 per cent to £3.1 billion. The biggest contributor was $790 million of net interest income, which rose 58 per cent, as Revolut placed more of its growing excess deposits with central banks, including the European Central Bank (ECB), and 'reputable financial institutions', according to the report.
The ECB deposit rate was 4 per cent for the first half of 2024, but had fallen to 3 per cent by the year end.
READ MORE
Card payment revenues – including fees on international money transfers, merchant fees for transaction processing, and charges on cash withdrawals outside customer plans – rose 43 per cent to £694 million.
Revenues from foreign exchange increased 58 per cent and those from wealth products rose 298 per cent to £422 million, driven by crypto and equities trading. Subscription revenues for its various plans – which are as expensive as €55 a month, for its Revolut Ultra card – advanced 74 per cent to £423 million.
Total customer balances rose by two thirds to £30 billion, including money held off Revolut's balance sheet in money market funds and with partner firms. Deposits held on balance sheet amounted to £22.3 billion, while its fledgling lending business – mainly personal loans – stood at £979.3 million, leading to a very low loan-to-deposits ratio of 4.4 per cent.
Revolut has previously said that it plans to start mortgage lending this year, initially in Lithuania, home to its euro zone banking licence, and followed by the Republic of Ireland, where customers rose 14 per cent last year to 3 million. Some three-quarters of adults in the State are now Revolut customers, according to the company.
'We began internally testing mortgages in 2024, moving us one step closer to being a part of one of the biggest financial decisions of our customers' lives,' group chief executive and co-founder Nik Storonsky said in the report.
Revolut received its second banking licence in Mexico earlier this month and is hoping to secure full authorisation in the UK – its main market, with more than 50 million customers – this year. UK regulators gave Revolut a restricted licence, following a three-year wait, last July, after the group managed to file its first annual report in years without needing a deadline extension.
Full banking authorisation in the UK is seen as a major milestone before an initial public offering (IPO) of the Softbank-backed group, which industry observers expect to take place next year.
The group was valued at $48 billion last month by Schroders Capital Global Innovation Trust, an investment trust that has a small stake in the company. That marked an upgrade from the $45 billion value last summer when Revolut completed a secondary share sale to provide more liquidity for employees.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Heart device sales help Boston Scientific beat profit estimates
Heart device sales help Boston Scientific beat profit estimates

Irish Examiner

timean hour ago

  • Irish Examiner

Heart device sales help Boston Scientific beat profit estimates

Biomedical firm Boston Scientific has raised its annual profit forecast after strong demand for its heart devices helped the US medical device maker beat second-quarter profit estimates. Shares of the Massachusetts-based company rose by over 3% in pre-market trading following the results. A rise in surgical procedures has benefited medical device manufacturers such as Boston Scientific, as it boosted sales and helped offset broader concerns about healthcare spending pressures. Analysts said hospital utilization trends were robust during the second quarter, with hospital checks pointing to high single-digit volume growth - well above the historical average. Boston Scientific's main growth drivers, Farapulse and Watchman, which use short high-voltage pulses to treat certain abnormal heart rhythm conditions, saw strong demand during the quarter. Farapulse, approved in the US to treat certain patients with intermittent atrial fibrillation, competes with Johnson & Johnson's Varipulse and Medtronic's PulseSelect in the market for pulsed field ablation systems. Rival Johnson & Johnson last week posted strong medtech sales, aided by its heart devices, Varipulse and Trupulse. The company reported net sales of $5.06bn (€4.33bn) during the second quarter beating estimates of $4.9bn. The majority of these sales, $3.2bn, were in the US with Europe, the Middle East, and Africa accounting for just $878m. The company's cardiovascular unit reported quarterly sales of $3.34bn, surpassing estimates of $3.20bn. 'Excellent quarter' Chairman and chief executive of Boston Scientific, Mike Mahoney, said it was another 'excellent quarter' for the company 'marked by exceptional top-line performance' which delivered 'margin expansion and prioritized investment for future growth'. Boston Scientific expects 2025 adjusted profit of $2.95 to $2.99 per share, up from the prior view of $2.87 to $2.94 earlier. It posted an adjusted profit of 75c per share for the second quarter, topping analysts' average estimate of 72 cents, according to data compiled by LSEG. Boston Scientific began operating in Ireland in 1994. It has a large campus in Cork as well as several other locations across the island. According to its company's Irish operations' most recent financial documents, it employed 6,405 during 2023. Reuters

Arsenal seal €73.5m Viktor Gyökeres deal after late-night breakthrough
Arsenal seal €73.5m Viktor Gyökeres deal after late-night breakthrough

Irish Times

time6 hours ago

  • Irish Times

Arsenal seal €73.5m Viktor Gyökeres deal after late-night breakthrough

Arsenal have finally reached agreement with Sporting for the transfer of Viktor Gyökeres in a deal worth up to €73.5m (£63.7m), having resolved the problematic issue of the €10m of add-ons to end a tortuous saga and Mikel Arteta's hunt for a striker. The London club, who are poised to confirm the signing of the centre-half Cristhian Mosquera from Valencia for an initial €15m, made the official breakthrough late on Tuesday, sending an updated offer to their Portuguese counterparts to satisfy them over the structure of the bonuses. Sporting have wanted the add-ons to be achievable, based on appearances, goals and assists by Gyökeres plus Champions League qualification, whereas Arsenal had wanted to include some more difficult ones. As the negotiations dragged at the end of last week, it is understood that Sporting felt €5m of Arsenal's proposed bonuses were achievable, €5m not so. One clause that was suggested related to Gyökeres winning the Ballon d'Or with Arsenal. The negotiations have been handled largely by the agents, with club-to-club contact at a minimum. Sporting are comfortable that the bonuses are achievable, allowing them to reflect on having effectively held out for what they wanted. READ MORE Sporting had demanded €70m plus €10m in add-ons; an €80m euro package was the target, albeit it was less than the €100m release clause in Gyökeres's contract. They have got there with a basic fee of €63.5m and the agents having agreed to waive their 10% cut of that – a saving to Sporting of €6.35m. The positions on both sides had long been entrenched, Gyökeres determined to force the move to Arsenal, ignoring interest from elsewhere; Sporting digging in hard for their money. There has been conflict, Gyökeres refusing to report back for pre-season training with Sporting but, at last, Arteta can look forward to working with his man. It was always going to be a pivotal summer for Arsenal and Gyökeres is the latest step in a spending spree. Arteta and the sporting director, Andrea Berta, have overseen the arrivals of Kepa Arrizabalaga, Martín Zubimendi, Christian Nørgaard and Noni Madueke for a combined £118.5m. Mosquera has travelled to Singapore to link up with the squad on their pre-season tour. The 21-year-old, who represented Spain at this summer's European Under-21 Championship, has signed a five-year contract which has the option of a further year. Gyökeres was a sensation at Sporting, scoring 97 goals in 102 appearances. Having signed for £20.5m from Coventry in the summer of 2023, the 27-year-old helped Sporting to the league title in each of his seasons with them – plus the Portuguese Cup in the last one. - Guardian

Ep 1- John Magnier's bitter land row and the €15m handshake deal
Ep 1- John Magnier's bitter land row and the €15m handshake deal

Irish Independent

time10 hours ago

  • Irish Independent

Ep 1- John Magnier's bitter land row and the €15m handshake deal

Today, the future of the 750-acre property is the subject of a trial that has seen a bitter land dispute play out before the High Court. John Magnier, the bloodstock billionaire, and two of his children, are seeking to enforce a handshake deal agreed between Mr Magnier and Richard Thomson-Moore to buy Barne Estate. Mr Magnier contends that the €15m deal agreed in his Coolmore home in Tipperary on August 22, 2023 with Mr Thomson-Moore is binding. He argues that a later €22.5m deal Mr Thomson-Moore and his family trust agreed with Maurice Regan, the US-based Kerry building tycoon, is 'unlawful'. Today on The Indo Daily, in the first of a two-part special, Fionnán Sheahan is joined by Mark Tighe, journalist with the Sunday Independent, to discuss one of the most dramatic and colourful cases to hit the Irish courts in recent memory.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store